SYRE   $41.895  -0.98% Market Open

Spyre Therapeutics, Inc.
Total Cash 426.00M
totalCashPerShare 8.387
EBITDA -172.55M
Total Debt 235.00K
quickRatio 19.257
currentRatio 19.697
Total Revenue 0.00
debtToEquity 0.063
Revenue/Share 0.0
ROA -0.31805
ROE -1.02092
grossProfits
freeCashflow -260.72M
operatingCashflow -156.42M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.46B
forwardPE -8.735218
floatShares 32.18M
sharesOutstanding 50.92M
sharesShort 8.41M
sharesShortPriorMonth 8.72M
dateShortInterest
sharesPercentSharesOut 0.17%
heldPercentInsiders 0.10%
heldPercentInstitutions 1.03%
Short Ratio help_outline 13.78%
shortPercentOfFloat 0.20%
impliedSharesOutstanding
bookValue 4.304
Price To Book help_outline 7.89
earningsQuarterlyGrowth
netIncomeToCommon -185.98M
trailingEps 10.89%
forwardEps -3.89%
enterpriseToEbitda -8.44
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.82 3Q 2024
institutionsCount 166
lastUpdated Nov. 2, 2024, 7:04 a.m.